SlideShare a Scribd company logo
Patch 1
Smoking Prevalence and Attributable
Disease Burden
INTRODUCTION
This research assesses global, national, and regional smoking mortality, morbidity, and
aetiologies in all 195 countries, by specifically identifying.
 The study designs.
 The validity
 Reliability
 Representativeness
 The comprehensiveness
 Does it understand people's interpretations?
 Whether it varies within the association & cause-and-effect relation. (PubMed.gov, 2017)
THE DESIGN OF STUDY
This study research is the analysis of an investigation study, analyzing the worldwide burden of
tobacco consumption(smoking) across the 195 countries around the year 1990 - 2015. The study
presents an update in the previously issued estimates of smoking diseases, injuries, death, and
risk factors depending on the outcomes of GBD 2015. The focus of the research is on the
prevalence and fatality rate, the variation in burden, and the Socio-demographic Index in tobacco
consumption (smoking) in the youth and old adults age groups, and the efficient intervention and
possible solution to provide better guidance strategies to target the main risk factors in every
possible new territory. (Marissa B Reitsma, 2017)
The development of smoking cessation, specifically following the implementation of the
Framework Convention on Smoking Prevention, is a main leading point in public health. Matter
of fact, smoking is a major risk factor for death and injury worldwide, necessitating persistent
governmental commitment. The Worldwide Impact of disease, injury, and risk factors analysis
(GBD) establishes a strong framework for evaluating global, national, and regional progress
toward smoking-related goals. (NCBI, 2017)
VALIDITY
In several epidemiological trials, cigarette smoking is a significant predictor. We assessed the
validation of tobacco smoking reports in initial health care by linking the prevalence of smoking
reports from initial medical care to public healthcare interview results. Smoking tobacco is a
significant key factor related to health, mainly in the cardio-pulmonary, digestive systems, and
cancers. Smoking cigarettes may be responsible for 19% of all mortality in the United Kingdom.
In epidemiological trials, tobacco smoking status is regularly investigated to determine exposure
and future inconsistency. In 1996, a previous report examined smoking level reports in early care
from the Clinical Practice Research Datalink. As opposed to national health survey results at the
time, both former and present smokers are significantly under-recorded. (Gulliford, 2013).
RELIABILITY
The outcomes collected with the Smoking the Timeline and Questionnaire Follow-back process
provided close relationships. A very limited variation found indicates that even an evaluation of
smokers can differ with respective customer response/ feedback, including a multi-item
developed method for measuring tobacco use with young adults might not be of sufficient value.
(Danielle E. Ramo, 2011)
Despite progress in tobacco prevention around the world, smoking continues to be a major risk
factor for premature mortality & morbidity. Amid some successes, multiple countries across the
world witnessed greater annualized rate levels of reduction in the smoking prevalence around
1990 and 2005 than the one between 2005 and 2015. Tobacco restriction and enhanced
surveillance are needed to minimize attributable burden and smoking prevalence even further.
(Christopher J L Murray, 2017)
REPRESENTATIVENESS
The representativeness of this study is shown by sample research that has been conducted. The
CPRD generated a representative group of individuals aged 30 to 100 years. The analysis was
part of a broader research of the antecedent factors of a chronic condition, and people under the
age of 30 were omitted due to a lesser risk for death. Every year around 1st January 2005 to 30th
April 2015, a sample size of 21 430 males and females was taken without substitution. Only
general practices in England were studied for this survey, which spanned the years 2007 to 2015.
(NCBI, 2017)
COMPREHANSIVENESS
The comprehensiveness of this research study is that the higher accomplishment in tobacco
prevention is probable, but it would necessitate reliable, comprehensive, and properly adopted
and executed strategies, which will necessitate national and global levels of governmental effort
beyond what is accomplished over the last three decades. (Marissa B Reitsma, 2017)
IS THERE ANY DIFFERENCE BETWEEN ASSOCIATION &
CASE-AND-EFFECT OF THIS STUDY?
This study shows a similarity between the DALY and Socio-demographic Index (SDI).
Conclude, the three major causes of smoking-attributable age-standardized DALYs for both
sexes in 2015 were cancers (276%), cardiovascular diseases (412%), and chronic respiratory
diseases (205%). Tobacco use was the leading risk factor for chronic respiratory diseases and
cancer, but it was just the 9th leading risk factor for cardiovascular disease. Between 2005 and
2015, the population increase was the most important factor in growing attributable pressure
related to smoking in low SDI countries.
The key causes of aggregate increases in attributed burden related to smoking differed by sex
and SDI level concerning the transition in smoking exposures Since 2005, almost all DALYs
caused by smoking has fallen by 118% (95 percent UI 0–139) in high-SDI states, the only SDI
category with a substantial decline in attributable burden for men. Only middle-SDI states have
seen a substantial decline in all-cause DALYs due to smoking for women (a 226 percent
decrease [90–328]) around 2005 and 2015. (PMC, 2017)
References
Christopher J L Murray, M. H. F. E. G., 2017. Smoking prevalence and attributable disease burden
in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease
Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
Danielle E. Ramo, S. M. H. a. J. J. P., 2011. Reliability and validity of self-reported smoking in an
anonymous online survey with young adults. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202069/
[Accessed 24 March 2021].
Gulliford, H. P. B. A. T. P. M. C., 2013. Validity of smoking prevalence estimatesfrom primary care
electronic health records compared with national population survey data for England, 2007 to 2011.
[Online]
Available at: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.3537
[Accessed 24 March 2021].
Marissa B Reitsma, N. F. M. N. J. S. S., 2017. Smoking prevalence and attributable disease burden in
195 countries and territories,1990–2015: a systematic analysis from the Global Burden of Disease
Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
Marissa B Reitsma, N. F. M. N. J. S. S., 2017. Smoking prevalence and attributable disease burden in
195 countries and territories,1990–2015: a systematic analysis from the Global Burden of Disease
Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
Marissa B Reitsma, N. F. M. N. J. S. S. A. A., 2017. Smoking prevalence and attributable disease
burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of
Disease Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
NCBI, 2017. Smoking prevalence and attributable disease burden in 195 countries and territories,
1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
NCBI, P., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories,
1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
PMC, N., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories,
1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online]
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/
[Accessed 24 March 2021].
PubMed.gov, 2017. Smoking prevalence and attributable disease burden in 195 countries and
territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.[Online]
Available at: https://pubmed.ncbi.nlm.nih.gov/28390697/
[Accessed 24 March 2021].

More Related Content

What's hot

Discuss following topic. minimum 250 words. when thinking abou
Discuss following topic. minimum 250 words. when thinking abouDiscuss following topic. minimum 250 words. when thinking abou
Discuss following topic. minimum 250 words. when thinking abou
AMMY30
 
Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...
Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...
Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...
Konstantinos Demertzis
 
Maternal and Child Mortality in the United States
Maternal and Child Mortality in the United StatesMaternal and Child Mortality in the United States
Maternal and Child Mortality in the United States
Institute for Health Metrics and Evaluation - University of Washington
 
Local Tobacco Control Profiles: July 2018
Local Tobacco Control Profiles: July 2018Local Tobacco Control Profiles: July 2018
Local Tobacco Control Profiles: July 2018
Public Health England
 
Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...
Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...
Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...
iosrphr_editor
 
Ciggaret smoking and fertility
Ciggaret smoking and fertilityCiggaret smoking and fertility
Ciggaret smoking and fertility
Debre Berhan University
 
HAQ index for 195 countries in 2016
HAQ index for 195 countries in 2016HAQ index for 195 countries in 2016
HAQ index for 195 countries in 2016
Diamond Key International Pty. Ltd.
 
Ltcp slideset july2018
Ltcp slideset july2018Ltcp slideset july2018
Ltcp slideset july2018
Public Health England
 
Local tobacco control profiles December 2018
Local tobacco control profiles December 2018Local tobacco control profiles December 2018
Local tobacco control profiles December 2018
Public Health England
 
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBINGTRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
with Wind
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
Δρ. Γιώργος K. Κασάπης
 
A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...
A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...
A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...
Δρ. Γιώργος K. Κασάπης
 
Asia House - Six insights into tobacco harm reduction
Asia House - Six insights into tobacco harm reductionAsia House - Six insights into tobacco harm reduction
Asia House - Six insights into tobacco harm reduction
Clive Bates
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Mary Beth Levin
 
Harm reduction - six insights
Harm reduction - six insightsHarm reduction - six insights
Harm reduction - six insights
Clive Bates
 
Maths report finalised
Maths report finalised Maths report finalised
Maths report finalised
Pang Shuen
 

What's hot (19)

Discuss following topic. minimum 250 words. when thinking abou
Discuss following topic. minimum 250 words. when thinking abouDiscuss following topic. minimum 250 words. when thinking abou
Discuss following topic. minimum 250 words. when thinking abou
 
PM25 and Asthma_Spiker_Final
PM25 and Asthma_Spiker_FinalPM25 and Asthma_Spiker_Final
PM25 and Asthma_Spiker_Final
 
Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...
Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...
Modeling and Forecasting the COVID-19 Temporal Spread in Greece: An Explorato...
 
Maternal and Child Mortality in the United States
Maternal and Child Mortality in the United StatesMaternal and Child Mortality in the United States
Maternal and Child Mortality in the United States
 
Local Tobacco Control Profiles: July 2018
Local Tobacco Control Profiles: July 2018Local Tobacco Control Profiles: July 2018
Local Tobacco Control Profiles: July 2018
 
Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...
Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...
Who are the Smokers and what Factors Influence Smoking among Amassoma Communi...
 
Ciggaret smoking and fertility
Ciggaret smoking and fertilityCiggaret smoking and fertility
Ciggaret smoking and fertility
 
HAQ index for 195 countries in 2016
HAQ index for 195 countries in 2016HAQ index for 195 countries in 2016
HAQ index for 195 countries in 2016
 
Ltcp slideset july2018
Ltcp slideset july2018Ltcp slideset july2018
Ltcp slideset july2018
 
Local tobacco control profiles December 2018
Local tobacco control profiles December 2018Local tobacco control profiles December 2018
Local tobacco control profiles December 2018
 
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBINGTRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
 
A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...
A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...
A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2...
 
Smoking Cessation Program
Smoking Cessation ProgramSmoking Cessation Program
Smoking Cessation Program
 
Asia House - Six insights into tobacco harm reduction
Asia House - Six insights into tobacco harm reductionAsia House - Six insights into tobacco harm reduction
Asia House - Six insights into tobacco harm reduction
 
Ijerph 08-00411
Ijerph 08-00411Ijerph 08-00411
Ijerph 08-00411
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]
 
Harm reduction - six insights
Harm reduction - six insightsHarm reduction - six insights
Harm reduction - six insights
 
Maths report finalised
Maths report finalised Maths report finalised
Maths report finalised
 

Similar to Smoking Prevalence & Attributable Disease Burden

Analysis for the global burden of disease study 2016 lancet 2017
Analysis for the global burden of disease study 2016   lancet 2017Analysis for the global burden of disease study 2016   lancet 2017
Analysis for the global burden of disease study 2016 lancet 2017
Luis Sales
 
Epidemiologic Principles and Measures Used to Address the Practi.docx
Epidemiologic Principles and Measures Used to Address the Practi.docxEpidemiologic Principles and Measures Used to Address the Practi.docx
Epidemiologic Principles and Measures Used to Address the Practi.docx
russelldayna
 
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
Univ. of Tripoli
 
RESEARCH Open AccessExposures to fine particulate air poll.docx
RESEARCH Open AccessExposures to fine particulate air poll.docxRESEARCH Open AccessExposures to fine particulate air poll.docx
RESEARCH Open AccessExposures to fine particulate air poll.docx
ronak56
 
Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...
Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...
Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...
Δρ. Γιώργος K. Κασάπης
 
NOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docx
NOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docxNOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docx
NOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docx
kendalfarrier
 
Benefits of Quitting Smoking.docx
Benefits of Quitting Smoking.docxBenefits of Quitting Smoking.docx
Benefits of Quitting Smoking.docx
4934bk
 
Tackling tuberculosis recent progress and challenges
Tackling tuberculosis recent progress and challengesTackling tuberculosis recent progress and challenges
Tackling tuberculosis recent progress and challenges
The Economist Media Businesses
 
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docxRunning Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
wlynn1
 
2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制 2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制
None
 
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal
Program, plan, policy, strategies and SWOT analysis  of COPD in Nepal Program, plan, policy, strategies and SWOT analysis  of COPD in Nepal
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal
DeepakPandey315
 
NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation
Julmiste35
 
Running head ASSIGNMENT 3 1ASSIGNMENT 3 4
Running head ASSIGNMENT 3 1ASSIGNMENT 3 4Running head ASSIGNMENT 3 1ASSIGNMENT 3 4
Running head ASSIGNMENT 3 1ASSIGNMENT 3 4
MalikPinckney86
 
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...
inventionjournals
 
ปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรค
ปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรคปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรค
ปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรค
Chuchai Sornchumni
 
Factors associated adherence to TB treatment in Georgia report (eng)
Factors associated adherence to TB treatment in Georgia report (eng)Factors associated adherence to TB treatment in Georgia report (eng)
Factors associated adherence to TB treatment in Georgia report (eng)
Ina Charkviani
 
Smoking and its effect on periodontium
Smoking and its effect on periodontiumSmoking and its effect on periodontium
Smoking and its effect on periodontium
Dr. Faheem Ahmed
 
Tobacco health512
Tobacco health512Tobacco health512
Tobacco health512
kguy2know
 
STA 544Homework 1Work on the following problem set and show yo.docx
STA 544Homework 1Work on the following problem set and show yo.docxSTA 544Homework 1Work on the following problem set and show yo.docx
STA 544Homework 1Work on the following problem set and show yo.docx
susanschei
 

Similar to Smoking Prevalence & Attributable Disease Burden (20)

Analysis for the global burden of disease study 2016 lancet 2017
Analysis for the global burden of disease study 2016   lancet 2017Analysis for the global burden of disease study 2016   lancet 2017
Analysis for the global burden of disease study 2016 lancet 2017
 
Epidemiologic Principles and Measures Used to Address the Practi.docx
Epidemiologic Principles and Measures Used to Address the Practi.docxEpidemiologic Principles and Measures Used to Address the Practi.docx
Epidemiologic Principles and Measures Used to Address the Practi.docx
 
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...Dr Yousef Elshrek is  One co-authors in this study >>>> Global, regional, and...
Dr Yousef Elshrek is One co-authors in this study >>>> Global, regional, and...
 
FINAL PROJECT
FINAL PROJECTFINAL PROJECT
FINAL PROJECT
 
RESEARCH Open AccessExposures to fine particulate air poll.docx
RESEARCH Open AccessExposures to fine particulate air poll.docxRESEARCH Open AccessExposures to fine particulate air poll.docx
RESEARCH Open AccessExposures to fine particulate air poll.docx
 
Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...
Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...
Δείκτης Ποιότητας και Διαθεσιμότητας της Ιατροφαρμακευτικής Περίθαλψης (Healt...
 
NOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docx
NOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docxNOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docx
NOTES FOR TWO MORE RESEARCH ARTICLES1The Effe.docx
 
Benefits of Quitting Smoking.docx
Benefits of Quitting Smoking.docxBenefits of Quitting Smoking.docx
Benefits of Quitting Smoking.docx
 
Tackling tuberculosis recent progress and challenges
Tackling tuberculosis recent progress and challengesTackling tuberculosis recent progress and challenges
Tackling tuberculosis recent progress and challenges
 
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docxRunning Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
 
2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制 2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制
 
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal
Program, plan, policy, strategies and SWOT analysis  of COPD in Nepal Program, plan, policy, strategies and SWOT analysis  of COPD in Nepal
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal
 
NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation
 
Running head ASSIGNMENT 3 1ASSIGNMENT 3 4
Running head ASSIGNMENT 3 1ASSIGNMENT 3 4Running head ASSIGNMENT 3 1ASSIGNMENT 3 4
Running head ASSIGNMENT 3 1ASSIGNMENT 3 4
 
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...
 
ปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรค
ปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรคปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรค
ปัจจัยทางสังคมทำให้เด็กๆต้องทุกข์เพราะวัณโรค
 
Factors associated adherence to TB treatment in Georgia report (eng)
Factors associated adherence to TB treatment in Georgia report (eng)Factors associated adherence to TB treatment in Georgia report (eng)
Factors associated adherence to TB treatment in Georgia report (eng)
 
Smoking and its effect on periodontium
Smoking and its effect on periodontiumSmoking and its effect on periodontium
Smoking and its effect on periodontium
 
Tobacco health512
Tobacco health512Tobacco health512
Tobacco health512
 
STA 544Homework 1Work on the following problem set and show yo.docx
STA 544Homework 1Work on the following problem set and show yo.docxSTA 544Homework 1Work on the following problem set and show yo.docx
STA 544Homework 1Work on the following problem set and show yo.docx
 

Recently uploaded

GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
shanicedivinagracia2
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
What Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdfWhat Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdf
Dharma Homoeopathy
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
renewlifehypnosis
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
BeshedaWedajo
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
aunty1x2
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 

Recently uploaded (20)

GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
What Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdfWhat Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdf
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 

Smoking Prevalence & Attributable Disease Burden

  • 1. Patch 1 Smoking Prevalence and Attributable Disease Burden INTRODUCTION This research assesses global, national, and regional smoking mortality, morbidity, and aetiologies in all 195 countries, by specifically identifying.  The study designs.  The validity  Reliability  Representativeness  The comprehensiveness  Does it understand people's interpretations?  Whether it varies within the association & cause-and-effect relation. (PubMed.gov, 2017) THE DESIGN OF STUDY This study research is the analysis of an investigation study, analyzing the worldwide burden of tobacco consumption(smoking) across the 195 countries around the year 1990 - 2015. The study presents an update in the previously issued estimates of smoking diseases, injuries, death, and risk factors depending on the outcomes of GBD 2015. The focus of the research is on the prevalence and fatality rate, the variation in burden, and the Socio-demographic Index in tobacco consumption (smoking) in the youth and old adults age groups, and the efficient intervention and possible solution to provide better guidance strategies to target the main risk factors in every possible new territory. (Marissa B Reitsma, 2017) The development of smoking cessation, specifically following the implementation of the Framework Convention on Smoking Prevention, is a main leading point in public health. Matter of fact, smoking is a major risk factor for death and injury worldwide, necessitating persistent
  • 2. governmental commitment. The Worldwide Impact of disease, injury, and risk factors analysis (GBD) establishes a strong framework for evaluating global, national, and regional progress toward smoking-related goals. (NCBI, 2017) VALIDITY In several epidemiological trials, cigarette smoking is a significant predictor. We assessed the validation of tobacco smoking reports in initial health care by linking the prevalence of smoking reports from initial medical care to public healthcare interview results. Smoking tobacco is a significant key factor related to health, mainly in the cardio-pulmonary, digestive systems, and cancers. Smoking cigarettes may be responsible for 19% of all mortality in the United Kingdom. In epidemiological trials, tobacco smoking status is regularly investigated to determine exposure and future inconsistency. In 1996, a previous report examined smoking level reports in early care from the Clinical Practice Research Datalink. As opposed to national health survey results at the time, both former and present smokers are significantly under-recorded. (Gulliford, 2013). RELIABILITY The outcomes collected with the Smoking the Timeline and Questionnaire Follow-back process provided close relationships. A very limited variation found indicates that even an evaluation of smokers can differ with respective customer response/ feedback, including a multi-item developed method for measuring tobacco use with young adults might not be of sufficient value. (Danielle E. Ramo, 2011) Despite progress in tobacco prevention around the world, smoking continues to be a major risk factor for premature mortality & morbidity. Amid some successes, multiple countries across the world witnessed greater annualized rate levels of reduction in the smoking prevalence around 1990 and 2005 than the one between 2005 and 2015. Tobacco restriction and enhanced surveillance are needed to minimize attributable burden and smoking prevalence even further. (Christopher J L Murray, 2017) REPRESENTATIVENESS The representativeness of this study is shown by sample research that has been conducted. The CPRD generated a representative group of individuals aged 30 to 100 years. The analysis was
  • 3. part of a broader research of the antecedent factors of a chronic condition, and people under the age of 30 were omitted due to a lesser risk for death. Every year around 1st January 2005 to 30th April 2015, a sample size of 21 430 males and females was taken without substitution. Only general practices in England were studied for this survey, which spanned the years 2007 to 2015. (NCBI, 2017) COMPREHANSIVENESS The comprehensiveness of this research study is that the higher accomplishment in tobacco prevention is probable, but it would necessitate reliable, comprehensive, and properly adopted and executed strategies, which will necessitate national and global levels of governmental effort beyond what is accomplished over the last three decades. (Marissa B Reitsma, 2017) IS THERE ANY DIFFERENCE BETWEEN ASSOCIATION & CASE-AND-EFFECT OF THIS STUDY? This study shows a similarity between the DALY and Socio-demographic Index (SDI). Conclude, the three major causes of smoking-attributable age-standardized DALYs for both sexes in 2015 were cancers (276%), cardiovascular diseases (412%), and chronic respiratory diseases (205%). Tobacco use was the leading risk factor for chronic respiratory diseases and cancer, but it was just the 9th leading risk factor for cardiovascular disease. Between 2005 and 2015, the population increase was the most important factor in growing attributable pressure related to smoking in low SDI countries. The key causes of aggregate increases in attributed burden related to smoking differed by sex and SDI level concerning the transition in smoking exposures Since 2005, almost all DALYs caused by smoking has fallen by 118% (95 percent UI 0–139) in high-SDI states, the only SDI category with a substantial decline in attributable burden for men. Only middle-SDI states have seen a substantial decline in all-cause DALYs due to smoking for women (a 226 percent decrease [90–328]) around 2005 and 2015. (PMC, 2017)
  • 4. References Christopher J L Murray, M. H. F. E. G., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021]. Danielle E. Ramo, S. M. H. a. J. J. P., 2011. Reliability and validity of self-reported smoking in an anonymous online survey with young adults. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202069/ [Accessed 24 March 2021]. Gulliford, H. P. B. A. T. P. M. C., 2013. Validity of smoking prevalence estimatesfrom primary care electronic health records compared with national population survey data for England, 2007 to 2011. [Online] Available at: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.3537 [Accessed 24 March 2021]. Marissa B Reitsma, N. F. M. N. J. S. S., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories,1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021]. Marissa B Reitsma, N. F. M. N. J. S. S., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories,1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021]. Marissa B Reitsma, N. F. M. N. J. S. S. A. A., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021].
  • 5. NCBI, 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021]. NCBI, P., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021]. PMC, N., 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. [Online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439023/ [Accessed 24 March 2021]. PubMed.gov, 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.[Online] Available at: https://pubmed.ncbi.nlm.nih.gov/28390697/ [Accessed 24 March 2021].